Hagens Berman Reminds Abbvie Abbv Investors Of Ongoing Investigation Of Abbvies Humira Sales Practices | Latest News RSS feed

Hagens Berman Reminds Abbvie Abbv Investors Of Ongoing Investigation Of Abbvies Humira Sales Practices - Latest News


Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira Sales Practices

SAN FRANCISCO, Nov. 9, 2018 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors in AbbVie Inc. (ABBV) of the Firm's ongoing investigation of AbbVie's Humira sales practices. If you purch... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us